Neuropeptide Y (NPY) is a 36 amino acid peptide neurotransmitter, which is widely expressed in the central and peripheral nervous systems of mammals. Neuropeptide Y has an important role in the stimulation of the appetite and is relevant to the pathophysiology of anxiety and depressionNeuropeptide Y is one of the most potent stimulators of feeding. At least five distinct G-protein coupled receptors (Y1, Y2, Y4, Y5, and Y6) mediate the actions of NPY. In rodents, repeated administration of Neuropeptide Y leads to hyperphagia and obesity associated with decreased thermogenesis in brown adipose tissue, hyperinsulinemia, hypercorticosteronaemia, reduced plasma testosterone concentrations, and insulin resistance in skeletal muscle. In the cardiovascular system Neuropeptide Y is found in neurons supplying the vasculature, cardiomyocytes, and endocardium, and is involved in physiological processes including vasoconstriction, cardiac remodeling, and angiogenesis. It is increasingly also implicated in cardiovascular disease pathogenesis, including hypertension, atherosclerosis, ischemia/infarction, arrhythmia, and heart failure. Neuropeptide Y is considered to be an anxiolytic endogenous peptide and its levels can be modulated by stress and it may also play a role in the etiology and pathophysiology of posttraumatic stress disorder.
Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 21:20:46 GMT 2025
by
admin
on
Mon Mar 31 21:20:46 GMT 2025
|
| Protein Sub Type | |
| Sequence Type | COMPLETE |
| Record UNII |
BY7U39XXK0
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
LOINC |
49866-7
Created by
admin on Mon Mar 31 21:20:46 GMT 2025 , Edited by admin on Mon Mar 31 21:20:46 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
D009478
Created by
admin on Mon Mar 31 21:20:46 GMT 2025 , Edited by admin on Mon Mar 31 21:20:46 GMT 2025
|
PRIMARY | |||
|
m7840
Created by
admin on Mon Mar 31 21:20:46 GMT 2025 , Edited by admin on Mon Mar 31 21:20:46 GMT 2025
|
PRIMARY | Merck Index | ||
|
16132350
Created by
admin on Mon Mar 31 21:20:46 GMT 2025 , Edited by admin on Mon Mar 31 21:20:46 GMT 2025
|
PRIMARY | |||
|
BY7U39XXK0
Created by
admin on Mon Mar 31 21:20:46 GMT 2025 , Edited by admin on Mon Mar 31 21:20:46 GMT 2025
|
PRIMARY | |||
|
DTXSID4037164
Created by
admin on Mon Mar 31 21:20:46 GMT 2025 , Edited by admin on Mon Mar 31 21:20:46 GMT 2025
|
PRIMARY | |||
|
NEUROPEPTIDE Y
Created by
admin on Mon Mar 31 21:20:46 GMT 2025 , Edited by admin on Mon Mar 31 21:20:46 GMT 2025
|
PRIMARY | |||
|
82785-45-3
Created by
admin on Mon Mar 31 21:20:46 GMT 2025 , Edited by admin on Mon Mar 31 21:20:46 GMT 2025
|
PRIMARY | |||
|
DB11788
Created by
admin on Mon Mar 31 21:20:46 GMT 2025 , Edited by admin on Mon Mar 31 21:20:46 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
Binding Assay
IC50
|
||
|
INHIBITOR -> TARGET |
InhibitS NPY-induced vasoconstriction.
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO_ACID_SUBSTITUTION | [1_36] | TYROSINAMIDE, L- | 05LU01CS4T |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:CALCULATED | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|